Our targeted ablation of Notch1 leading to reduced GBM growth and enhanced radiosensitivity offers further evidence of a role of Notch1 in glioma pathogenesis and in cellular response to irradiation damages. Here, NOTCH1 is linked to central nervous system cancer.